Skip to Main Content

Author Details

Wuqiang Zhu
Mayo Clinic
2006
62
29
Jake Y. Chen (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36657638Integrated proteomics reveals alterations in sarcomere composition and developmental processes during postnatal swine heart development.J Mol Cell Cardiol2023
36583992Development and Characterization of Isogenic Cardiac Organoids from Human-Induced Pluripotent Stem Cells Under Supplement Starvation Regimen.ACS Biomater Sci Eng2023
36512179Gene Therapy for Cardiomyocyte Renewal: Cell Cycle, a Potential Therapeutic Target.Mol Diagn Ther2023
36473799Gastroenteropancreatic Neuroendocrine Tumor Metastasis to the Heart: Evaluation of Imaging Manifestations.Curr Probl Diagn Radiol2023
36671774Nanoparticle Based Cardiac Specific Drug Delivery.Biology (Basel)2023
36657638Integrated proteomics reveals alterations in sarcomere composition and developmental processes during postnatal swine heart development.J Mol Cell Cardiol2023
36583992Development and Characterization of Isogenic Cardiac Organoids from Human-Induced Pluripotent Stem Cells Under Supplement Starvation Regimen.ACS Biomater Sci Eng2023
36473799Gastroenteropancreatic Neuroendocrine Tumor Metastasis to the Heart: Evaluation of Imaging Manifestations.Curr Probl Diagn Radiol2023
36512179Gene Therapy for Cardiomyocyte Renewal: Cell Cycle, a Potential Therapeutic Target.Mol Diagn Ther2023
36671774Nanoparticle Based Cardiac Specific Drug Delivery.Biology (Basel)2023
35326403Optogenetic Control of Engrafted Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Live Mice: A Proof-of-Concept Study.Cells2022
35707727Identification of metabolic pathways underlying FGF1 and CHIR99021-mediated cardioprotection.iScience2022
35513306Nanofiber capsules for minimally invasive sampling of biological specimens from gastrointestinal tract.Acta Biomater2022
35660800Turning back the clock: A concise viewpoint of cardiomyocyte cell cycle activation for myocardial regeneration and repair.J Mol Cell Cardiol2022
35326403Optogenetic Control of Engrafted Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Live Mice: A Proof-of-Concept Study.Cells2022
35707727Identification of metabolic pathways underlying FGF1 and CHIR99021-mediated cardioprotection.iScience2022
35660800Turning back the clock: A concise viewpoint of cardiomyocyte cell cycle activation for myocardial regeneration and repair.J Mol Cell Cardiol2022
35513306Nanofiber capsules for minimally invasive sampling of biological specimens from gastrointestinal tract.Acta Biomater2022
33951921Cyclin D2 Overexpression Enhances the Efficacy of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Myocardial Repair in a Swine Model of Myocardial Infarction.Circulation2021
33951921Cyclin D2 Overexpression Enhances the Efficacy of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Myocardial Repair in a Swine Model of Myocardial Infarction.Circulation2021
33929841Minimally Invasive Delivery of 3D Shape Recoverable Constructs with Ordered Structures for Tissue Repair.ACS Biomater Sci Eng2021
33928139Circular RNAs and Cardiovascular Regeneration.Front Cardiovasc Med2021
34722687Metabolic Profile in Neonatal Pig Hearts.Front Cardiovasc Med2021
34651028<i>De novo</i> Drug Delivery Modalities for Treating Damaged Hearts: Current Challenges and Emerging Solutions.Front Cardiovasc Med2021
33928139Circular RNAs and Cardiovascular Regeneration.Front Cardiovasc Med2021
33929841Minimally Invasive Delivery of 3D Shape Recoverable Constructs with Ordered Structures for Tissue Repair.ACS Biomater Sci Eng2021
34722687Metabolic Profile in Neonatal Pig Hearts.Front Cardiovasc Med2021
34651028<i>De novo</i> Drug Delivery Modalities for Treating Damaged Hearts: Current Challenges and Emerging Solutions.Front Cardiovasc Med2021
31350544N-cadherin overexpression enhances the reparative potency of human-induced pluripotent stem cell-derived cardiac myocytes in infarcted mouse hearts.Cardiovasc Res2020
31907992Targeting exosome-associated human antigen R attenuates fibrosis and inflammation in diabetic heart.FASEB J2020
32064254Optogenetics: Background, Methodological Advances and Potential Applications for Cardiovascular Research and Medicine.Front Bioeng Biotechnol2020
32117968Utilization of Human Induced Pluripotent Stem Cells for Cardiac Repair.Front Cell Dev Biol2020
32169551CHIR99021 and fibroblast growth factor 1 enhance the regenerative potency of human cardiac muscle patch after myocardial infarction in mice.J Mol Cell Cardiol2020
32277708Fluorescent indicators for continuous and lineage-specific reporting of cell-cycle phases in human pluripotent stem cells.Biotechnol Bioeng2020
32453715Myocardial protection by nanomaterials formulated with CHIR99021 and FGF1.JCI Insight2020
33195180Editorial: Nanotechnology in Cardiovascular Regenerative Medicine.Front Bioeng Biotechnol2020
32671049Nanoparticle-Mediated Drug Delivery for Treatment of Ischemic Heart Disease.Front Bioeng Biotechnol2020
32724973Three-dimensional scaffold-free microtissues engineered for cardiac repair.J Mater Chem B2020
31350544N-cadherin overexpression enhances the reparative potency of human-induced pluripotent stem cell-derived cardiac myocytes in infarcted mouse hearts.Cardiovasc Res2020
31907992Targeting exosome-associated human antigen R attenuates fibrosis and inflammation in diabetic heart.FASEB J2020
32064254Optogenetics: Background, Methodological Advances and Potential Applications for Cardiovascular Research and Medicine.Front Bioeng Biotechnol2020
33195180Editorial: Nanotechnology in Cardiovascular Regenerative Medicine.Front Bioeng Biotechnol2020
32671049Nanoparticle-Mediated Drug Delivery for Treatment of Ischemic Heart Disease.Front Bioeng Biotechnol2020
32724973Three-dimensional scaffold-free microtissues engineered for cardiac repair.J Mater Chem B2020
32117968Utilization of Human Induced Pluripotent Stem Cells for Cardiac Repair.Front Cell Dev Biol2020
32277708Fluorescent indicators for continuous and lineage-specific reporting of cell-cycle phases in human pluripotent stem cells.Biotechnol Bioeng2020
32169551CHIR99021 and fibroblast growth factor 1 enhance the regenerative potency of human cardiac muscle patch after myocardial infarction in mice.J Mol Cell Cardiol2020
32453715Myocardial protection by nanomaterials formulated with CHIR99021 and FGF1.JCI Insight2020
30423020Targeted expression of cyclin D2 ameliorates late stage anthracycline cardiotoxicity.Cardiovasc Res2019
31629738Cardiomyocytes from CCND2-overexpressing human induced-pluripotent stem cells repopulate the myocardial scar in mice: A 6-month study.J Mol Cell Cardiol2019
  • 1 - 50 of 124

Recommended Authors

Wangping Chen
The Second Xiangya Hospital, Central South University
Career Start Year 2017
Number of shared co-authors 14
Paola Cattaneo
Humanitas Clinical and Research Center-IRCCS
Career Start Year 2009
Number of shared co-authors 1
James L Engel
David Geffen School of Medicine, University of California los angeles
Career Start Year 2009
Number of shared co-authors 0
Billy Chen
Cedars-Sinai Medical Center
Career Start Year 2005
Number of shared co-authors 0
Yu Huang
Gladstone Institutes San Francisco
Career Start Year 2004
Number of shared co-authors 1
Guoqing Du
Second Affiliated Hospital of Harbin Medical University
Career Start Year 2004
Number of shared co-authors 0
Preeti Ahuja
David Geffen School of Medicine, University of California at Los Angeles
Career Start Year 2004
Number of shared co-authors 1
Li Zhang
Brigham and Women's Hospital and Harvard Medical School
Career Start Year 2003
Number of shared co-authors 0
Michael Xavier Doss
BioMarin Pharmaceutical Inc.
Career Start Year 2003
Number of shared co-authors 0
Kurt Pfannkuche
University Clinics of Cologne
Career Start Year 2002
Number of shared co-authors 0
Huamin Liang
Tongji Medical College
Career Start Year 2002
Number of shared co-authors 0
Alexander von Gise
Hannover Medical School
Career Start Year 2001
Number of shared co-authors 1
Egbert Bisping
Medical University of Graz
Career Start Year 2001
Number of shared co-authors 1
Kevin Bersell
Vanderbilt University
Career Start Year 2001
Number of shared co-authors 0
David A Liem
University of California davis
Career Start Year 2001
Number of shared co-authors 1
Junbo Ge
Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases
Career Start Year 1999
Number of shared co-authors 1
Javier E L??pez
and Cardiovascular Research Institute, University of California davis
Career Start Year 1998
Number of shared co-authors 0
Stephane Heymans
Maastricht University Medical Centre
Career Start Year 1998
Number of shared co-authors 0
Julie R McMullen
Baker Heart and Diabetes Institute
Career Start Year 1998
Number of shared co-authors 1
Bin Zhou
The Central Hospital of Shaoyang
Career Start Year 1998
Number of shared co-authors 2
Robert Passier
University of Twente
Career Start Year 1995
Number of shared co-authors 0
Peter M Kang
Beth Israel Deaconess Medical Center, Harvard Medical School
Career Start Year 1993
Number of shared co-authors 1
William R MacLellan
University of Washington
Career Start Year 1993
Number of shared co-authors 1
Reza Ardehali
University of California los angeles
Career Start Year 1993
Number of shared co-authors 1
Deepak Srivastava
Gladstone Institutes San Francisco
Career Start Year 1989
Number of shared co-authors 2
Kenneth B Margulies
Perelman School of Medicine at the University of Pennsylvania
Career Start Year 1988
Number of shared co-authors 1
Douglas B Sawyer
Center for Molecular Medicine, Maine Medical Center Research Institute
Career Start Year 1985
Number of shared co-authors 0
Seigo Izumo
Beth Israel Deaconess Medical Center.
Career Start Year 1984
Number of shared co-authors 1
Christine L Mummery
Leiden University Medical Center
Career Start Year 1981
Number of shared co-authors 0
Steven R Houser
Cardiovascular Research Center, Lewis Katz School of Medicine, Temple University
Career Start Year 1979
Number of shared co-authors 3

Collaborators

Jianyi Zhang
University of Alabama at Birmingham, 1670 University Boulevard
Co-authored papers 23
Meng Zhao
National Engineering Research Center of Cell Products, AmCellGene Engineering Co.
Co-authored papers 10
Yawen Tang
University of Alabama at Birmingham, 1670 University Boulevard
Co-authored papers 6
Anton V Borovjagin
University of Alabama at Birmingham
Co-authored papers 6
Gregory P Walcott
University of Alabama at Birmingham
Co-authored papers 5
Prasanna Krishnamurthy
Co-authored papers 4
Chengming Fan
Institute of Genetics and Developmental Biology, Chinese Academy of Sciences
Co-authored papers 4
Philippe Menasché
Co-authored papers 3
Ying Ge
University of Wisconsin-Madison
Co-authored papers 3
Gangjian Qin
University of Alabama at Birmingham, 1670 University Boulevard
Co-authored papers 3
Daniel J Garry
University of Minnesota
Co-authored papers 3
Nenad Bursac
Co-authored papers 2
Timothy J Kamp
Co-authored papers 2
Sumanth D Prabhu
Co-authored papers 2
Jack M Rogers
Co-authored papers 2
Roberto Bolli
Co-authored papers 2
Gordana Vunjak-Novakovic
Co-authored papers 2
Dora Dias-Santagata
Co-authored papers 2
Yaoliang Tang
Co-authored papers 2
Yibin Wang
Co-authored papers 2
Eric Zhang
University of Alabama at Birmingham.
Co-authored papers 2
Michael C Fishbein
Co-authored papers 2
John P Cooke
Co-authored papers 1
William T Pu
Boston Children's Hospital, Harvard Medical School
Co-authored papers 1
Gerald W Dorn
Co-authored papers 1
Weihua Bian
Binzhou Medical University
Co-authored papers 1
Thanh Nguyen
University of Alabama at Birmingham
Co-authored papers 1
Jiacheng Sun
University of Alabama at Birmingham.
Co-authored papers 1
Joel L Berry
Co-authored papers 1
Jake Y Chen
Co-authored papers 1
Release 1.2